RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SUVEN.NS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Suven Life Sciences Limited stock downgraded to Sell Candidate
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Suven Life Sciences Limited stock price gained 0.0500% on the last trading day (Thursday, 28th Mar 2024), rising from ₹99.95 to ₹100.00. During the last trading day the stock fluctuated 2.50% from a day low at ₹100.00 to a day high of ₹102.50. The price has risen in 6 of the last 10 days and is up by 0.91% over the past 2 weeks. Volume fell on the last day by -149 thousand shares and in total, 116 thousand shares were bought and sold for approximately ₹11.61 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Suven Life Sciences Limited stock with a 90% probability to be traded between ₹77.14 and ₹121.15 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

SUVEN.NS Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Suven Life Sciences Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at ₹104.89. On a fall, the stock will find some support from the short-term average at ₹99.77. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, January 12, 2024, and so far it has fallen -20.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Suven Life Sciences Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at ₹93.30 and ₹92.20. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Suven Life Sciences Limited finds support just below today's level at ₹93.30. If this is broken, then the next support from accumulated volume will be at ₹92.20 and ₹88.80.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ₹2.50 between high and low, or 2.50%. For the last week, the stock has had daily average volatility of 4.28%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SUVEN.NS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Suven Life Sciences Limited to open at ₹100.83, and during the day (based on 14 day Average True Range), to move between ₹94.90 and ₹105.10, which gives a possible trading interval of +/-₹5.10 (+/-5.10%) up or down from last closing price. If Suven Life Sciences Limited takes out the full calculated possible swing range there will be an estimated 10.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at ₹101.05 (1.05%) than the support at ₹93.30 (6.70%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Suven Life Sciences Limited stock A Buy?

Suven Life Sciences Limited holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.089 Sell Candidate Downgraded

Predicted Opening Price for Suven Life Sciences Limited of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
₹100.83 ( 0.83%) ₹100.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for SUVEN.NS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 103.33 3.33 %
R2 102.38 2.38 %
R1 101.79 1.79 %
Current price: 100.00
Support S1 99.88 -0.122 %
S2 99.29 -0.712 %
S3 98.33 -1.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 121.20 21.20 %
R2 105.40 5.40 %
R1 101.05 1.05 %
Current price 100.00
Support S1 93.30 -6.70%
S2 92.20 -7.80%
S3 88.80 -11.20%

SUVEN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 29, 2019 Feb 14, 2019 Feb 25, 2019 ₹1.38 0.591%
2 Jan 19, 2018 Feb 06, 2018 Feb 15, 2018 ₹1.38 0.699%
3 Jan 23, 2017 Feb 08, 2017 Feb 16, 2017 ₹0.92 0.529%
4 Mar 05, 2016 Mar 14, 2016 Mar 23, 2016 ₹0.92 0.478%
5 May 26, 2015 Jul 23, 2015 Sep 13, 2015 ₹0.553 0.238%

FAQ

What is the symbol for Suven Life Sciences Limited Stock and on which exchange is it traded?
The symbol for Suven Life Sciences Limited is SUVEN.NS and it is traded on the NSE (National Stock Exchange of India).

Should I buy or sell Suven Life Sciences Limited Stock?
Suven Life Sciences Limited holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Suven Life Sciences Limited Stock?
Suven Life Sciences Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Suven Life Sciences Limited Stock.

What's the current price of Suven Life Sciences Limited Stock?
As of the end of day on the 2024-03-28, the price of an Suven Life Sciences Limited (SUVEN.NS) share was ₹100.00.

What is the 52-week high and low for Suven Life Sciences Limited Stock?
The 52-week high for Suven Life Sciences Limited Stock is ₹129.00 and the 52-week low is ₹45.80.

What is the market capitalization of Suven Life Sciences Limited Stock?
As of the 2024-03-28, the market capitalization of Suven Life Sciences Limited is 21.807B.

When is the next earnings date for Suven Life Sciences Limited?
The upcoming earnings date for Suven Life Sciences Limited is May 07, 2024.
Click to get the best stock tips daily for free!

About Suven Life Sciences Limited

Suven Life Sciences Limited Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NCEs) in central nervous system therapies. Its product candidates include SUVN-502 for the treatment of A... SUVEN.NS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT